z-logo
open-access-imgOpen Access
Mortality, cardiovascular risk, and androgen deprivation therapy for prostate cancer
Author(s) -
LucieMarie Scailteux,
Florian Naudet,
Q. Alimi,
S. Vincendeau,
Emmanuel Oger
Publication year - 2016
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000003873
Subject(s) - medicine , androgen deprivation therapy , prostate cancer , relative risk , placebo , myocardial infarction , randomized controlled trial , antiandrogen , observational study , stroke (engine) , meta analysis , oncology , cancer , confidence interval , pathology , mechanical engineering , alternative medicine , engineering
Supplemental Digital Content is available in the text

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here